Cancer Treatment Centers of America: Clincal Trials
Learn More About This Topic: Chat with Us | Email Us
Randomized, Double-Blind, Multicenter, Phase 2 Trial Comparing Veliparib Plus Carboplatin and Paclitaxel versus Placebo Plus Carboplatin and Paclitaxel in Previously Untreated Metastatic or Advanced Non-Small-Cell Lung Cancer (NSCLC)
This study is for patients who have been diagnosed with metastatic or advanced Non-Small Cell Lung Cancer (NSCLC) and have not received prior chemotherapy for their metastatic NSCLC. The study will assess the effect of the addition of Veliparib to carboplatin and paclitaxel compared to carboplatin and paclitaxel alone.
For More Information:
Please contact one of our Oncology Information Specialists at 1-800-615-3055 to learn more about this clinical trial. Oncology Information Specialists are available 24 hours a day, 7 days a week, 365 days a year.